United Therapeutics Corp (NASDAQ:UTHR)

134.93
Delayed Data
As of Feb 16
 -1.18 / -0.87%
Today’s Change
112.01
Today|||52-Week Range
169.89
-8.80%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues1.1B1.3B1.5B1.6B
 
 
 
 
 
Cost of Goods Sold99.9M93.6M36.1M41.1M
 
 
 
 
 
Depreciation And Amortization31.3M32.2M32.9M31.6M
 
 
 
 
 
 
Operating ExpensesGross Income985.9M1.2B1.4B1.5B
 
 
 
 
 
General Expenses693.4M623.8M697.7M464.4M
 
 
 
 
 
Research And Development299.3M242.5M245.1M147.6M
 
 
 
 
 
Total Operating Expenses824.5M749.7M766.7M537.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income292.5M538.8M699.0M1.1B
 
 
 
 
 
Extraordinary Credit210.0K0.000.000.00
 
 
Extraordinary Charge0.00-1.1M0.000.00
 
 
Interest Expense On Debt18.1M17.6M4.7M3.9M
 
 
 
 
 
Other Expenses425.0K5.1M350.2M2.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income278.9M525.2M1.0B1.1B
 
 
 
 
 
Income Taxes-104.3M-185.1M-392.8M-346.5M
 
 
 
 
 
Net Income174.6M340.1M651.6M713.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS50.1M48.2M46.0M43.8M
 
 
 
 
 
Shares To Calculate EPS Diluted53.2M54.2M51.2M46.8M
 
 
 
 
 
 
Earnings Per ShareEPS$3.28$6.28$12.72$15.25
 
 
 
 
 
EPS Diluted$3.28$6.28$12.72$15.25